BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20227455)

  • 1. Effects of sub-chronic clozapine and haloperidol administration on brain lipid levels.
    Barakauskas VE; Ypsilanti AR; Barr AM; Innis SM; Honer WG; Beasley CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):669-73. PubMed ID: 20227455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats.
    Levant B; Crane JF; Carlson SE
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):728-32. PubMed ID: 16442197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice.
    Isaac G; Fredriksson A; Danielsson R; Eriksson P; Bergquist J
    FEBS J; 2006 May; 273(10):2232-43. PubMed ID: 16649999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB/c mice.
    Cheng CY; Hong CJ; Tsai SJ
    Life Sci; 2005 Mar; 76(19):2269-73. PubMed ID: 15733941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.
    Schmitt A; May B; Müller B; Jatzko A; Petroianu G; Braus DF; Henn FA
    Pharmacopsychiatry; 2003 Nov; 36(6):292-6. PubMed ID: 14663653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
    Huang XF; Tan YY; Huang X; Wang Q
    Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine.
    Ko F; Tallerico T; Seeman P
    Synapse; 2006 Aug; 60(2):141-51. PubMed ID: 16715494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat.
    Barbaccia ML; Affricano D; Purdy RH; Maciocco E; Spiga F; Biggio G
    Neuropsychopharmacology; 2001 Oct; 25(4):489-97. PubMed ID: 11557162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia.
    Banerjee SP; Zuck LG; Yablonsky-Alter E; Lidsky TI
    Neuroreport; 1995 Dec; 6(18):2500-4. PubMed ID: 8741750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine or Haloperidol in rats prenatally exposed to methylazoxymethanol, a compound inducing entorhinal-hippocampal deficits, alter brain and blood neurotrophins' concentrations.
    Fiore M; Di Fausto V; Iannitelli A; Aloe L
    Ann Ist Super Sanita; 2008; 44(2):167-77. PubMed ID: 18660566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
    Behav Brain Res; ; . PubMed ID: 17559953
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.